A novel homozygous mutation of the AIRE gene in an APECED patient from Pakistan: case report and review of the literature by Pellegrino, Marsha et al.
August 2018 | Volume 9 | Article 18351
Case RepoRt
published: 13 August 2018
doi: 10.3389/fimmu.2018.01835
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Andrew R. Gennery, 
Newcastle University, 
United Kingdom
Reviewed by: 
Yuval Itan, 
Icahn School of Medicine at 
Mount Sinai, United States  
Michail Lionakis, 
National Institute of Allergy and 
Infectious Diseases (NIAID), 
United States
*Correspondence:
Alessandra Fierabracci  
alessandra.fierabracci@opbg.net
Specialty section: 
This article was submitted to 
Primary Immunodeficiencies, 
a section of the journal 
Frontiers in Immunology
Received: 24 April 2018
Accepted: 25 July 2018
Published: 13 August 2018
Citation: 
Pellegrino M, Bellacchio E, Dhamo R, 
Frasca F, Betterle C and Fierabracci A 
(2018) A Novel Homozygous 
Mutation of the AIRE Gene in 
an APECED Patient From 
Pakistan: Case Report and 
Review of the Literature. 
Front. Immunol. 9:1835. 
doi: 10.3389/fimmu.2018.01835
a Novel Homozygous Mutation of the 
AIRE Gene in an apeCeD patient 
From pakistan: Case Report and 
Review of the Literature
Marsha Pellegrino1, Emanuele Bellacchio2, Rudina Dhamo3, Federica Frasca1, 
Corrado Betterle4 and Alessandra Fierabracci1*
1 Infectivology and Clinical Trials Research Division, Bambino Gesù Children’s Hospital, Rome, Italy, 2 Molecular Genetics 
and Functional Genomics, Genetics and Rare Diseases Research Division, Bambino Gesù Children’s Hospital, Rome, Italy, 
3 Pediatric Division, Jesi Hospital, Jesi, Italy, 4 Endocrine Unit, Department of Medicine (DIMED), University of Padua,  
Padua, Italy
Autoimmune-poly-endocrinopathy-candidiasis–ectodermal-dystrophy syndrome (APECED) 
is a rare monogenic recessive disorder caused by mutations in the autoimmune regulator 
(AIRE) gene. Criteria for the diagnosis of APECED are the presence of two of the follow-
ing disorders: chronic mucocutaneous candidiasis (CMC), chronic hypoparathyroidism 
(CHP), and Addison’s disease. APECED develops at high incidence in Finns, Sardinians, 
and Iranian Jews and presents with a wide range of clinical phenotypes and genotypes. 
In this manuscript, we report the clinical, endocrinological, and molecular features of a 
16-year-old female patient from Pakistan living in Italy and presenting the major APECED
clinical manifestations CMC, CHP, and primary adrenal insufficiency. Premature ovar-
ian failure, chronic bronchopneumopathy, vitiligo, Hashimoto’s thyroiditis emerged as
associated diseases. In our patient, AIRE gene screening revealed the novel c.396G>C 
(p.Arg132Ser; p.R132S) mutation in homozygosity thus confirming APECED diagno-
sis. This is the first reported mutation within the nuclear localization signal (NLS) that 
is associated with APECED. The NLS mutation affects the nuclear import of classical 
transcription factors through nuclear pore by recognition of nuclear import receptors, 
the importin α molecules. By displaying crystal structures of the peptide containing the 
KRK basic residue cluster bound to α importins, we show that p.R132S replacement in 
131-KRK-133 does not reproduce these interactions. Thus, we propose that the novel
mutation exerts its pathogenetic effect by impairing the nuclear import of the Aire protein.
The present case report is added to a limited series of Pakistani APECED patients who
we reviewed from the scientific literature, mostly diagnosed on clinical findings.
Keywords: apeCeD, AIRE gene, genotype/phenotype correlation, mutation functional analysis, epidemiology
INtRoDUCtIoN
A 16-year-old female patient (weight at birth 3 kg) was the third child of consanguineous parents, 
without any family history for autoimmune diseases. Older brother died for unknown reason at the 
age of 11 years, the four living children, two males and two females, are in apparently good health 
at the age of 19, 6, 11.5, and 10, respectively (Figure 1). The patient and her family come originally 
FIGURe 1 | Genetic analysis of the AIRE gene. (a) Electropherograms of representative fragments of exon 3 of the AIRE gene relative to a normal control and the 
patient. The analysis was performed after informed consent. The wild-type allele for exon 3 is shown for the control (upper panel). The patient (bottom panel) is 
homozygous revealing two copies of the mutated c.396G>C allele (exon 3). Fifty normal controls tested negative for the novel mutation. (B) The phylogenetic tree 
relative to the family studies showing the heterozygous state for the novel c.396G>C mutation in both parents and the homozygosity in the patient’s DNA.
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from Pakistan. From the age of 3 years, the patient and her family 
live in continental Italy.
From the age of 2 years, the patient was affected by onichodys-
trophy at the right thumb. The patient was diagnosed for chronic 
hypoparathyroidism (CHP) at the age of 8  years and started 
therapy with calcium carbonate and calcitriol per os; she was 
diagnosed for Addison’s disease (AD) from the age of 14.7 years 
and started therapy with hydrocortisone and fludrocortisone 
per os. Currently, the patient presents dehydration episodes with 
hyponatremia. The patient is also affected by chronic obstructive 
bronchopneumopathy and dust mites allergy, in therapy with flu-
ticasone and salbutamol intranasal administration, vitiligo, and 
Hashimoto’s thyroiditis with normal thyroid function. Menarche 
appeared at 13.2 years of age with a hypergonadotropic hypog-
onadism at the age of 14.8. At present, the patient is under proges-
terone treatment. At the age of 14.7 years, oral and fecal swab and 
scraping sample cultures obtained from the patient’s nails showed 
Candida albicans proliferation suggesting the diagnosis of chronic 
mucocutaneous candidiasis (CMC) at present under miconazole 
treatment. Organ and non-organ specific autoantibodies (Abs) 
screening revealed positivity for thyroid peroxidase (TPO) and 
thyroglobulin (Tg) Abs indicative of Hashimoto’s thyroiditis, 
for 21 hydroxylase (21OH Abs) revealing autoimmune AD, for 
17αOH, cytochrome P450 Side Chain Cleavage Enzyme (P450scc 
Abs) indicative of a premature ovarian failure due to lymphocytic 
oophoritis, for aromatic l-amino acid decarboxylase (AADC) 
Abs indicative of autoimmune enteropathy (1, 2), although the 
patient does not present gastrointestinal dysfunction (ID), and 
for type 1 interferon (IFN) Abs, i.e., IFN-ω (test carried out at 
FIRS Laboratories, Cardiff, UK) (3) and IFN-α (test carried out at 
Laboratory of Human Genetics of Infectious Diseases, INSERM, 
Paris, France) (Figure S1 in Supplementary Material, Table  1) 
(4) which are typical of APECED patients. CMC-related neutral-
izing IL-17A, IL-17F, and IL-22 Abs tested negative (4, 5). Abs 
to tryptophan hydroxylase (TPH) (1), to acetylcholine receptor, 
to nuclear (ANA), to mitochondrial (AMA), to smooth muscle 
(SMA), to liver-kidney microsomal, and to parietal cell (PCA) 
were tested and showed to be negative (Table 1). Interestingly, 
the serum of both parents was tested and proved to be positive 
for IFN-ω Abs at low titer (7.0  IU cutoff ≤5  IU) in absence of 
autoimmune disease manifestations.
Identification of c.396G>C Mutation and 
Its effect on Nuclear Localization signal 
(NLs) Function
The novel autoimmune regulator (AIRE) gene c.396G>C 
(p.Arg132Ser) (exon 3) mutation in homozygosity was detected 
confirming APECED diagnosis (Figure 1). Homozygous c.1578T>C 
(p.Asp526=, rs1133779) (exon 14) synonymous variant was also 
detected.
Arg132 resides in the Aire protein region that comprises the 
functional NLS responsible for the protein correct subcellular 
localization and thus its activity (Figure  2). To show how the 
taBLe 1 | Data related to the present case report and published Pakistani APECED patients.
age Clinical manifestation/therapy abs profile Laboratory and instrumental parameters
From 2 years 
old
Onychomycosis at right thumb Mycelial fungi cultures negative
8 years old Hypoparathyroidism under calcium carbonate and 
calcitriol treatment
ptH ↓, Ca ↓, p↑
10.5 years 
old
Chronic allergic obstructive bronchopneumopathy 
under treatment with fluticasone and salbutamol
Dust mites positive prick test
14 years old Vitiligo
14.6 years 
old
Secondary amenorrhea under progesterone  
treatment
FsH ↑, LH↑, progesterone↓, estradiol↓
14.7 years Primary adrenal insufficiency under hydrocortisone  
and fludrocortisone treatment
aCtH ↑, basal cortisol ↓, cortisoluria in 
24 h ↓, aCtH test: no cortisol increase, 
aldosterone↓, plasma renin activity ↑, 
DHeas↓, Na ↓, K ↑
Chronic mucocutaneous candidiasis under  
miconazole treatment
oral, fecal swab confirming Candida 
albicans proliferation
Hashimoto’s thyroiditis in euthyroidism tpo abs 79 cutoff ≤25, tg abs 418 cutoff 
≤40, ANA, AMA, ASMA, LKMA neg, PCA neg
Dental enamel dysplasia 21oH abs 0.7 cutoff ≤0.4 IU, 17αoH abs 
5.9 cutoff ≤1 IU, p450scc abs >32 cutoff 
≤1 IU, aaDC abs 102.4 cutoff ≤2.7 IU, 
AChR Abs neg, TPH Abs neg, IFN-ω abs 76 
cutoff ≤5 IU, IFN-α abs pos, IFN-17A Abs 
neg, IFN-17F Abs neg, IL-22 Abs neg
Homozygous c.396G>C AIRE gene 
mutation
Clinical presentation, laboratory and instrumental parameters of the APS1 patient (altered parameters are in bold).
Pos, positive; neg, negative; PTH, parathyroid hormone; Ca, serum calcium; P, serum phosphorus; FSH, follicle-stimulating hormone; LH, luteinizing hormone; ACTH, 
adrenocorticotropic hormone; DHEAS, dehydroepiandrosterone; Na, serum sodium; K, serum potassium; IL, interleukin; AChR, acetylcholine receptor; LKMA, liver-kidney 
microsomal; TPH, tryptophan hydroxylase; Abs, autoantibodies; TPO, thyroid peroxidase; IFN, interferon.
FIGURe 2 | Aire protein analysis representation. Schematic representation of Aire protein is shown along with the protein sequence alignment of the region 
surrounding the site of the p.R132S amino acid replacement among vertebrates. The functional nuclear localization signal (NLS) (6) is highlighted.
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p.R132S replacement in 131-KRK-133 influences the function 
of the NLS, we have displayed crystal structures of an NLS 
peptide containing the identical KRK basic residue cluster 
bound to α-importins. As observed in Figure 2 and Figure S2 
in Supplementary Material, the central arginine (corresponding 
to Aire Arg 132) makes a multiplicity of interactions with 
α-importins regardless the KRK cluster is bound to the minor 
or the major NLS-binding site. These interactions cannot be 
reproduced by replacement with the tiny and uncharged serine 
residue.
taBLe 2 | Clinical and genetic features of a small series of Pakistani APECED patients reported between 2006 and 2018 including the present case report.
patients sex age at 
referral
age of first 
symptom
AIRE mutation Major clinical manifestations 
related to apeCeD
other clinical 
manifestations
Reference
1 F 15 8 Exon 3: homozygous 
c.396G>C 
p.Arg132Ser
Adrenal insufficiency, chronic 
hypoparathyroidism, chronic 
mucocutaneous candidiasis
Vitiligo, POF, 
Hashimoto’s 
thyroiditis, enamel 
dysplasia, chronic 
bronchopneumopathy
Present report
Exon 14: c.1578T>C 
p.Asp526=
2 F 17 Childhood 
(<14)
NA Chronic mucocutaneous 
candidiasis (oral ulcers), Addison’s 
disease (hyperpigmentation)
(33)
3 F 8 6 Not tested Chronic mucocutaneous 
candidiasis, Addison’s 
disease (hyperpigmentation), 
hypoparathyroidism
Nail dystrophy, vitiligo, 
epileptiform seizures, 
Alcaligenes faecalis 
septicemia
(34)
4 NA NA NA Exon 8: homozygous 
c.967_979del13
NA NA (5)
5 NA NA NA NA NA NA (35)
6 F NA NA NA NA Renal failure Unpublished (Harachi, Pakistan) 
2010
NA, information not available; POF, premature ovarian failure.
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BaCKGRoUND
The autoimmune-poly-endocrinopathy-candidiasis–ectoder-
mal-dystrophy/dysplasia (APECED) or autoimmune polyendo-
crine syndrome type 1 is a rare monogenic recessive autoimmune 
syndrome caused by mutations in the AIRE gene [reviewed in 
Ref. (7)]. This gene encodes for the thymus-enriched transcrip-
tion factor Aire responsible for central immune tolerance being 
involved both in the deletion of autoreactive T cells by negative 
selection and in controlling processing/presentation of autoan-
tigens within the thymus [reviewed in Ref. (7, 8)]. Aire protein 
is not only detected in immunologically important tissues as 
thymic medullary epithelial cells but also in peripheral blood 
and in the monocyte/dendritic cell lineage (9–12). This diverse 
expression could explain the variability of symptoms in APECED 
patients. Among the immunological abnormalities, a defect in 
CD4+CD25+ regulatory T cells, key mediators in peripheral tol-
erance and prevention of autoimmunity, contributes to APECED 
pathogenesis [reviewed in Ref. (7, 13–15)].
The old criteria for the clinical diagnosis of APECED were 
based on the presence of at least two of the following disor-
ders: CMC, CHP, and primary adrenal insufficiency or AD. 
Furthermore, 78% of APECED patients present non-endocrine 
manifestations before the first endocrinopathy is manifested 
(16). New criteria for the diagnosis of APECED were introduced 
in 2009 (17) based on genetic and immunological features of 
the syndrome, independently from the phenotypical clinical 
manifestations.
APECED develops at high incidence (1:9,000–1:25,000) in 
Finns, Sardinians, and Iranian Jews. These ethnicities present the 
“signature” homozygous AIRE mutations c.769C>T (R257X), 
c.415C>T (R139X), and c.254A>G (Y85C), respectively (16, 
18–20). More than 80–90% of APECED patients present CMC 
as first symptom (16, 19, 20). APECED is detected at lower 
incidences (approximately 1:90,000–3:100,000) and with greater 
genetic variability (17, 21–31) in many European countries such 
as Slovenia, Slovakia, Russia, Great Britain, France, Italy, Ireland, 
Poland, and other Scandinavian countries (i.e., Norway, Sweden). 
In American APECED patients was observed an enrichment 
of organ-specific non-endocrine manifestations (40–80% of 
patients) appearing early in life, compared with European 
APECED cohorts. The diverse clinical picture included urticarial 
eruption, autoimmune hepatitis, autoimmune gastritis, autoim-
mune ID, autoimmune pneumonitis, and SjÖgren-like syndrome 
(32).
In this manuscript, we report a female APECED patient from 
Pakistan with a newly discovered homozygous AIRE gene muta-
tion and review the literature on published APECED Pakistani 
patients.
DIsCUssIoN
Among the classic clinical features, this Pakistani female patient 
presented all fundamental APECED symptoms of the classic 
triad: CMC, CHP, and AD. Interestingly, circulating 21OH, 
17αOH, P450scc, AADC, TPO, Tg, and IFN-ω Abs were tested 
and found positive (Table  1). Interestingly, the serum of both 
parents also turned out positive for IFN-ω Abs at low titer without 
any autoimmune disorder being present. The presence of the 
novel c.396G>C (p.Arg132Ser) homozygous mutation of the 
AIRE gene confirms the diagnosis of APECED syndrome based 
on the new criteria (17, 32).
To the best of our knowledge, a limited series of APECED 
patients have been reported in the Pakistani population, mostly 
diagnosed on clinical findings. We reviewed the literature pub-
lished from 2006 to date (Table 2) (5, 33–35) on a series of six 
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APECED patients including the present case report (female/male 
ratio of 4:2, median age at referral 15  years; range 8–17  years) 
with early disease onset (median 8 years, age range 6–14 years, 
based on the appearance of the first component of the triad) and 
severe phenotype (on average, four manifestations per patient) 
(Table 2).
Interestingly, the novel diagnostic c.396G>C variant of the 
present case report is the first NLS localized mutation within the 
AIRE gene that is associated with APECED (6). In this regard, 
the Aire protein contains several functional domains, in addition 
to NLS, two plant homeodomain-type zinc fingers, four nuclear 
receptor-binding LXXLL motifs, homogeneously staining region 
(HSR), and SAND [Sp100, speckled protein 100 kDa, NucP41/75, 
nuclear phosphoprotein 41/75, DEAF-1 (deformed epidermal 
autoregulatory factor-1)] domains [reviewed in Ref. (6, 36)]. Aire 
acts as a transcriptional transactivator in vitro [reviewed in Ref. 
(6, 7, 37)] by DNA binding and interaction with the common 
coactivator CREB (cAMP-response element binding)-binding 
protein (CBP) [reviewed in Ref. (6, 38)].
Aire protein, both endogenous and transiently expressed, is 
predominantly localized in the cell nucleus where it regulates the 
expression of peripheral tissue antigens by different mechanisms 
either sequence-specific and/or epigenetic (9). When transiently 
expressed, Aire can be found in the cytoplasm attached to 
intermediate filaments or complexed within aggregates (9); 
therefore, in cells Aire can be shuttled between the nucleus and 
the cytoplasm. A nuclear export signal is also contained within 
the Aire HSR domain. The NLS is bipartite and constituted of 
amino acids 110–114 and 131–133 (6). Classic transcription 
factors containing typical NLSs are transported into the nucleus 
through nuclear pores by recognition of nuclear import receptors 
(39), the importin α molecules. The generated complex is bound 
by importin β that mediates its translocation into the nucleus in a 
Ran-GTPase-dependent manner (39). Incani et al. (40) proposed 
that lysine’s acetylation increased Aire stability inside the nucleus; 
conversely, Aire interaction with deacetylase complexes halts 
protein transactivation activity making it susceptible to proteo-
somal degradation.
In this work, we present the Aire p.R132S amino acid replace-
ment that directly affects the central basic residue in the active 
NLS of Aire (amino acids 131–133) as demonstrated by Ilmarinen 
et al. (6). These authors identified the functional NLS region in 
Aire by carrying out mutagenesis analysis within the two adjacent 
clusters of basic amino acids 110-RKGRK-114 and 131-KRK-133 
(mutations: R113A, K114E, R113A + K114A, K131E, R132A, or 
K133A) and observed loss of nuclear localization of the protein 
only with arginine/lysine replacements in the latter region, 
which was therefore proposed to work as a monopartite NLS. 
In addition, they found that Aire nuclear import occurs through 
the classical importin α/β pathway and the binding to various 
members of α-importin family.
In our study, we show that the p.R132S replacement in 131-
KRK-133 influences the function of NLS, by displaying crystal 
structures of a NLS peptide containing the identical KRK basic 
residue cluster bound to α-importins. The central arginine (cor-
responding to Aire Arg132) makes a multiplicity of interactions 
with α-importins regardless the KRK cluster is bound to the 
minor or the major NLS-binding site. Serine replacement does 
not reproduce these interactions. Thus, we propose that the 
p.R132S in Aire exerts its pathogenic effect by impairing the 
nuclear import of the protein.
So far, about 115 AIRE mutations have been identified in 
the APS-1 syndrome (30). Most of these variants, distributed 
throughout coding and non-coding regions, are either non-
sense or frameshift mutations that generate truncated protein 
sequences or single amino acid missense variants [reviewed 
in Ref. (41, 42)]. The diverse spectrum of variants can include 
single-nucleotide substitutions, insertions, and deletions with 
protein splicing effects. In addition, beside the conventional 
mutation analysis, even large genomic deletions can alter AIRE 
gene sequence [reviewed in Ref. (41, 42)]. Of note, the here 
reported novel AIRE mutation is the first NLS mutation affect-
ing Aire shuttling to the nucleus that is associated with APS-1 
syndrome.
Regarding clinical penetrance of known AIRE gene muta-
tions, these are assumed to be inherited in an autosomal reces-
sive manner. Nevertheless, p.G228W mutation of the SAND 
domain exceptionally follows a dominant inheritance pattern 
(43). Furthermore, monoallelic dominant-negative AIRE muta-
tions were also reported in literature as associated with milder 
autoimmune phenotypes (44). Regarding the novel p.Arg132Ser 
mutation of the present report, the absence of autoimmune mani-
festations within the family and the heterozygosity of the parents 
suggest autosomal recessive transmission.
Epidemiological investigations have shown that AIRE signa-
tures have been identified in peculiar ethnicities, i.e., in Finns 
[c.769C>T (R257X)], Sardinians [c.415C>T (R139X)], and 
Iranian Jews [c.254A>G (Y85C)] (16, 19, 20). In the light of the 
foregoing, expanded population studies based on AIRE gene 
screening in Pakistan would be necessary, since a very limited 
number of APECED patients, mostly diagnosed on clinical find-
ings, is reported nowadays in the scientific literature (Table 2). On 
a general ground, definitely, genetic screening along with genetic 
counseling and accurate anamnesis especially in family members 
of consanguineous marriages would help identify heterozygote 
carriers of AIRE gene mutations in the Pakistani population (7, 
41, 45). This extended approach would improve early diagnosis 
and avoid severe disease complications in newly affected patients. 
Furthermore, the relevance of the novel c.396G>C mutation 
would be unraveled by proving its diagnostic efficacy in associa-
tion with the clinical phenotype and the detection of IFN-ω Abs 
in this ethnicity.
MateRIaLs aND MetHoDs
Molecular studies: AIRE screening
All 14 exons and intronic regions of the AIRE gene were 
sequenced according to already described protocols (Genetic 
Analyzer 3500 Applied Biosystems HITACHI system, Thermo 
Fisher Scientific, Rodano, Italy) in the DNA of the 16-year-old 
patient, her 46.1-year-old mother, and her 48.3-year-old father 
(41). Parental consent was obtained for the study.
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structural and Conservation analysis at 
the site of the p.arg132ser Mutation
To display the mode of binding of the 131-KRK-133 fragment of 
Aire as a NLS to α-importins, we employed the crystal structures 
of the A89NLS peptide (VHKTVLGKRKYW), which carries 
identical cluster of positive residues, in its complex with the 
minor NLS-binding site of importin subunit α-1a from Oryza 
sativa (Protein Data Bank, PDB, 4B8P), and with the major 
NLS-binding site of importin subunit α-1 from mouse (PDB 
4BA3). Multiple sequence alignment was made around Arg132 to 
highlight the conservation of this residue and of the cationic-type 
amino acids in the 131–133 interval characterizing the NLS of the 
protein. The software Muscle was used (46).
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